Literature DB >> 2308481

Persistence of hepatitis B virus DNA after serological clearance of hepatitis B virus.

Y Tanaka1, M Esumi, T Shikata.   

Abstract

Using Southern blot technique, the state of hepatitis B virus (HBV) DNA in liver tissue was investigated in 16 patients who were sero-negative for hepatitis B surface antigen (HBsAg) but positive for its antibody (anti-HBs). In only one case, was HBV DNA found in liver tissue in a heterogeneously integrated form. In this case, digestion with Taq I demonstrated integrated HBV DNA as two definite bands at 1.8 and 0.5 kbp. This suggests that HBV DNA in some cases persists even after HBV infection has been cleared serologically. It is possible that this persistence of HBV DNA plays an important role in hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2308481     DOI: 10.1111/j.1600-0676.1990.tb00429.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  7 in total

Review 1.  KASL clinical practice guidelines for management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2019-06-12

2.  Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management.

Authors:  Chun-Jen Liu; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Hepatol Int       Date:  2011-06-14       Impact factor: 6.047

3.  Hepatitis B-related events in autologous hematopoietic stem cell transplantation recipients.

Authors:  Ozcan Ceneli; Zübeyde Nur Ozkurt; Kadir Acar; Seyyal Rota; Sahika Zeynep Aki; Zeynep-Arzu Yeğin; Münci Yağci; Seren Ozenirler; Gülsan Türköz Sucak
Journal:  World J Gastroenterol       Date:  2010-04-14       Impact factor: 5.742

Review 4.  KASL clinical practice guidelines: management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

5.  KASL Clinical Practice Guidelines: Management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2012-06-26

6.  Chemotherapy-related reactivation of hepatitis B infection: updates in 2013.

Authors:  Hwi Young Kim; Won Kim
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

7.  KASL clinical practice guidelines for management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2022-04-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.